Cultrera, R.; Libanore, M.; Barozzi, A.; d’Anchera, E.; Romanini, L.; Fabbian, F.; De Motoli, F.; Quarta, B.; Stefanati, A.; Bolognesi, N.;
et al. Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study. Antibiotics 2020, 9, 640.
https://doi.org/10.3390/antibiotics9100640
AMA Style
Cultrera R, Libanore M, Barozzi A, d’Anchera E, Romanini L, Fabbian F, De Motoli F, Quarta B, Stefanati A, Bolognesi N,
et al. Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study. Antibiotics. 2020; 9(10):640.
https://doi.org/10.3390/antibiotics9100640
Chicago/Turabian Style
Cultrera, Rosario, Marco Libanore, Agostino Barozzi, Erica d’Anchera, Letizia Romanini, Fabio Fabbian, Francesco De Motoli, Brunella Quarta, Armando Stefanati, Niccolò Bolognesi,
and et al. 2020. "Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study" Antibiotics 9, no. 10: 640.
https://doi.org/10.3390/antibiotics9100640
APA Style
Cultrera, R., Libanore, M., Barozzi, A., d’Anchera, E., Romanini, L., Fabbian, F., De Motoli, F., Quarta, B., Stefanati, A., Bolognesi, N., & Gabutti, G.
(2020). Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study. Antibiotics, 9(10), 640.
https://doi.org/10.3390/antibiotics9100640
